- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr King Davis Explains the Privacy Dangers of Digitizing Archives, Including Psychiatric Records
More and more archives and databases, including psychiatric hospital records, are being digitized for preservation, but this can present privacy risks from hacking, cautioned King Davis, PhD, faculty member, University of Texas at Austin School of Information.
More and more archives and databases, including psychiatric hospital records, are being digitized for preservation, but this can present privacy risks from hacking, cautioned King Davis, PhD, faculty member, University of Texas at Austin School of Information.
Transcript
As databases and archives become digitized, how does that affect the access and privacy of psychiatric records?
It puts everything at risk. There’s nothing in a digital database, and we all know that very clearly, from the lawsuits that have been there, from the access to banking records, DNA records. Particularly I guess over the last several days, there has been a lot of discussion whether or not, I think it’s a DNA database that police around the country have been using to track down serial murderers or persons who committed crimes from years ago. There’s been some real question raised about that.
So we don’t think that we have the expertise at this point to be able to say with assurance that those records that are in an electronic database are not going to be hacked. That’s certainly possible. Wikileaks, Facebook, all of these mechanisms have been hacked. So part of what we think is valuable and one of the recommendations that we make is that we think there ought to be a federal standard, a federal policy, a federal requirement, that all of the states could really begin to look at and decipher as the most meaningful way that they could protect the identities of persons, given the possibility of hacking.
NGS-Based Test Accurately Detects Post–Allo-HSCT Relapse in AML, MDS
February 21st 2025The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
“Expanding Access Isn’t Just About Fairness—It’s About Building Better Treatments for Everyone”
February 16th 2025Regina Barragan-Carrillo, MD, a postdoctoral fellow at City of Hope Comprehensive Cancer Center, discussed findings that show 76% of renal cell carcinoma trials take place in wealthy countries, amid news that clinical trial access for the world's poor may become even more challenging.
Read More
Amid Debate Over Diversity, RCC Trials Still Struggle to Reflect Patient Populations
February 16th 2025Abstracts presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium reflect the ongoing challenge with enrolling diverse patient populations in trials, despite stated goals.
Read More
